METHYCLOTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Methyclothiazide patents expire, and what generic alternatives are available?
Methyclothiazide is a drug marketed by Chartwell Rx, Ivax Pharms, Mylan, Norvium Bioscience, Par Pharm, Usl Pharma, and Watson Labs. and is included in fifteen NDAs.
The generic ingredient in METHYCLOTHIAZIDE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYCLOTHIAZIDE?
- What are the global sales for METHYCLOTHIAZIDE?
- What is Average Wholesale Price for METHYCLOTHIAZIDE?
Summary for METHYCLOTHIAZIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 15 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Patent Applications: | 4,128 |
DailyMed Link: | METHYCLOTHIAZIDE at DailyMed |